Device Trial Radar · NCT07937579
Efficacy and Safety of High-Flow Nasal Cannula During Transcatheter Closure Procedures
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Dec 1, 2026
Primary completion
Jul 31, 2027
Study completion Jul 31, 2027
Sponsor
- Lead sponsor
- Fu Jen Catholic UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 16, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Supportive care
- FDA-regulated device
- No
- Who can join
- All sexes, from 6 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to evaluate the efficacy and safety of high-flow nasal cannula oxygen therapy, compared with standard nasal cannula oxygen therapy, as respiratory support during transcatheter closure procedures for congenital heart disease under non-intubated deep sedation.
Conditions
- Congenital Heart Disease
- High Flow Nasal Canula
Interventions
High-flow nasal cannulaDevice
Heated, humidified high-flow oxygen will be delivered through a nasal cannula.
Conventional nasal cannulaDevice
Oxygen will be delivered through a nasal cannula.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of hypoxemiaTime frame: From initiation of the assigned oxygen therapy to completion of transcatheter closure procedure
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Fu Jen Catholic University Hospital, Fu Jen Catholic University
New Taipei City, Taiwan
National Taiwan University Hospital Yunlin Branch
Yunlin, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.